Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Agenus Was Rising High on Tuesday

TheMotleyFool

0 0

A rather up-and-down stock even in the up-and-down world of biotech, Agenus (NASDAQ: AGEN) was seeing a bit of a peak on Tuesday. In mid-afternoon trading, the company's shares were up by 7.5% on the back of an encouraging earnings report.

That morning, Agenus published its Q3 results. These showed that the immuno-oncology-focused biotech booked just under $253 million in revenue, well up from the $14.8 million in the same quarter last year. It also earned a net profit -- specifically, $177.3 million ($0.72 per share), a dramatic improvement over the nearly $52 million the company lost in Q3 2020.

Image source: Getty Images.

Source Fool.com

Like: 0

AGEN

Share